Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify how pimecrolimus cream 1% modifies the molecular and
cellular changes associated with the post-lesional phase of atopic dermatitis (AD). Healthy
volunteers and patients with atopic dermatitis will be studied.